About: FRI0280 Efficacy and Safety of Tocilizumab as First Line Therapy in Patients with Recent Polymyalgia Rheumatica (PMR): Results of the First Longitudinal Prospective Study (Tenor)

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: FRI0280 Efficacy and Safety of Tocilizumab as First Line Therapy in Patients with Recent Polymyalgia Rheumatica (PMR): Results of the First Longitudinal Prospective Study (Tenor) Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : data.idref.fr associated with source document(s)

Attributes	Values
Author	Cornec, Divi (1982-....) Renaudineau, Yves (1969-....) Marhadour, Thierry (1979-....) Saraux, Alain (1962-....) Devauchelle-Pensec, Valérie (1968-....) Berthelot, Jean-Marie
Bibliographic Citation	Devauchelle V., Berthelot J.-M., Cornec D., Renaudineau Y., Marhadour T., Jousse-Joulin S., Querellou S., Guarrigues F., De Bandt M., Gouillou M., Saraux A.. FRI0280 Efficacy and Safety of Tocilizumab as First Line Therapy in Patients with Recent Polymyalgia Rheumatica (PMR): Results of the First Longitudinal Prospective Study (Tenor). Annual European Congress of Rheumatology, Jun 2015, Rome, Italy. ⟨10.1136/annrheumdis-2015-eular.2727⟩
Title	FRI0280 Efficacy and Safety of Tocilizumab as First Line Therapy in Patients with Recent Polymyalgia Rheumatica (PMR): Results of the First Longitudinal Prospective Study (Tenor)
dc:date	2015

Faceted Search & Find service v1.13.91 as of Aug 16 2018

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of May 14 2019, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (70 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software